Scaffold-Based Multi-Objective Drug Candidate Optimization
This addresses the problem of handling vast data in high-throughput virtual screening for drug discovery, offering an incremental improvement in multi-parameter optimization methods.
The paper tackled the challenge of optimizing multiple physiochemical properties in drug candidate design by introducing ScaMARS, a scaffold-based graph Markov chain Monte Carlo framework, which achieved a 99.5% success rate and 84.6% diversity score in benchmarks.
In therapeutic design, balancing various physiochemical properties is crucial for molecule development, similar to how Multiparameter Optimization (MPO) evaluates multiple variables to meet a primary goal. While many molecular features can now be predicted using \textit{in silico} methods, aiding early drug development, the vast data generated from high throughput virtual screening challenges the practicality of traditional MPO approaches. Addressing this, we introduce a scaffold focused graph-based Markov chain Monte Carlo framework (ScaMARS) built to generate molecules with optimal properties. This innovative framework is capable of self-training and handling a wider array of properties, sampling different chemical spaces according to the starting scaffold. The benchmark analysis on several properties shows that ScaMARS has a diversity score of 84.6\% and has a much higher success rate of 99.5\% compared to conditional models. The integration of new features into MPO significantly enhances its adaptability and effectiveness in therapeutic design, facilitating the discovery of candidates that efficiently optimize multiple properties.